喀什有名的妇科门诊(喀什割包茎手术预约) (今日更新中)

Having an adequate supply of personal protective equipment could have saved the state of California hundreds of millions of dollars and stopped roughly 18,000 essential workers from getting the coronavirus, according to a new study from the University of California Berkeley.Researchers at the school looked at the cost of PPE and the early costs and infection rates of coronavirus in California. They conclude with a recommendation that the state stockpile PPE for a future pandemic.The team’s first data point is based on supply and demand; purchasing PPE when it is not high in demand, then saving it for when it's needed. According to the study, the cost of purchasing the same amount of PPE when there was not a global demand would be 17 percent of what the projected cost is now during the pandemic.“Maintaining the stockpile would be cheaper than real-time purchases even if it was not needed for another 35 years, and even if we were fortunate enough to not need the stockpile for longer than that, it would be a highly financially prudent form of insurance,” the researchers stated.Between mid-March and mid-July, roughly 250,000 healthcare workers in California filed for unemployment benefits because there was not sufficient PPE for them to go to work.For each week those healthcare workers could not report to work, it cost the state million in unemployment benefits. The researchers conclude millions could be saved by having the personal protective equipment available.Looking at rates of infection and studies from Europe showing transmission rates at hospitals, Berkeley researches believe almost 18,000 coronavirus cases among essential workers could have been prevented with an adequate supply of PPE.“If those worker cases had been avoided, an estimated 3,030 secondary cases among household members could have also been avoided, thus totaling at least 20,860 cases that could have been averted,” the study states.A separate survey conducted in June and July asked California’s skilled nursing facility staff about equipment; more than 20 percent reported still having inadequate supplies of PPE, and 80 percent said they were very or extremely concerned about workplace infection.The Berkeley study also appears to give support to California Senate Bill 275 as amended in July 2020, that “would require the state to create a PPE stockpile sufficient to protect healthcare and other essential workers for at least 90-days of a future pandemic or health emergency.” 2496

Harvey Weinstein is facing new allegations of sex trafficking and rape.A German actress, using the pseudonym Emma Loman, filed a federal lawsuit in Los Angeles on Monday, alleging that Weinstein raped her during the Cannes Film Festival in 2006. She is suing Weinstein for violation of human trafficking laws, assault, battery and false imprisonment, according to court documents obtained by CNN."Our client brings her claims in an effort to achieve justice for herself, and she hopes that by doing so she can help open the door to justice for the women in her industry who have undergone similar experiences," John G. Balestriere, the attorney handling Loman's claim, said in a statement to CNN. "Mr. Weinstein must answer these allegations and be held accountable for any damage he has caused our client."Phyllis Kupferstein, an attorney representing Weinstein, told CNN in a statement, "This lawsuit is an attempt to continue the legal barrage and public attention on Mr. Weinstein. The allegations are untrue and the claims are barred by the statute of limitations. We intend to immediately move to dismiss the complaint."According to the suit, Loman said she met with Weinstein at his hotel suite in Cannes, France to discuss starring in an upcoming film project he was producing, but he soon started making sexual advances towards her."Upon arriving at Weinstein's suite, however, Weinstein quickly dropped his professional demeanor," the suit states. "He instead overpowered Loman and raped her. Shocked and betrayed, Loman did not know what to do. Furthering Loman's disorientation, Weinstein proceeded to treat the rape like a standard component of their business, as if the professional discussion he offered Loman had actually taken place."Related: Harvey Weinstein seeks dismissal of indictment due to emails between him and accuserLoman also claims that Weinstein threatened her not to speak of the assault.This is the second sex trafficking case filed against Weinstein.Last week, a federal judge in New York ruled that British actress Kadian Noble can move forward with her sex trafficking lawsuit against the disgraced media mogul.Noble accuses Weinstein of sexually assaulting her in a hotel bathroom in Cannes, France in 2014 after luring her with talk of a potential movie role.Noble filed suit in November against Harvey Weinstein and his brother and then-business partner Bob Weinstein.US District Court Judge Robert W. Sweet granted Bob Weinstein's motion for dismissal but denied one from Harvey Weinstein.The judge wrote it would be the first instance in which a plaintiff asked for the Trafficking Victims Protections Act to be applied to conduct like that alleged in the lawsuit.Weinstein's lawyer said the act should not be applied."A typical sex trafficking case is someone who lures underage girls on the promise of a green card and locking them up in a basement and forcing them to have sex for money," Kupferstein said in a statement at the time.Weinstein, who also is facing criminal charges in New York, has denied all allegations of "non-consensual sexual activity."Weinstein has pleaded not guilty to six felony sex crimes -- two counts of predatory sexual assault, two counts of rape, one first-degree criminal sex act charge and one criminal sex act.Related: Sex trafficking lawsuit against Harvey Weinstein can proceed, judge rulesThe charges stem from allegations from three women, according to court documents. Weinstein remains free after posting million cash bail.The charges against Weinstein came nine months after The New Yorker and The New York Times published accounts from several women accusing him of various forms of sexual misconduct.In a recent interview with CNN, Ben Brafman, Weinstein's New York criminal attorney, said it would be "difficult but not impossible" to seat an impartial jury should Weinstein's case move forward to trial."I hope to find 12 people in Manhattan who may have heard a lot of the allegations against Mr. Weinstein but will give the court their sworn assurances that they will decide this case based on the evidence that comes into the courtroom and not on what they made have read, or what they may have heard," Brafman said. "I think part of what we're trying to suggest in these motions to dismiss is that contrary to what people may have read and may have heard, there is another side here."CNN's Cheri Mossburg and Judy Oehling contribute to this report.The-CNN-Wire 4463

George Floyd's daughter is now a stockholder in Disney, thanks to Barbra Streisand.Gianna Floyd announced the news on her Instagram page."Thank You, @barbrastreisand, for my package. I am now a Disney Stockholder, thanks to you!" Floyd posted. 251

Here are the Greek names for the 2020 Atlantic Hurricane Season for reference. pic.twitter.com/YsrpliN9fF— National Hurricane Center (@NHC_Atlantic) September 18, 2020 175

Holidays will look different this year for many Americans, with dinners outside, social distancing, or passing on family gatherings altogether. But several companies developing rapid at-home COVID-19 tests are hopeful that won't be the case next year. The goal is to make inexpensive, easy-to-use COVID tests that can deliver results in minutes, just like a pregnancy test. "For people to feel comfortable to associate with friends or family, there needs to be a testing methodology ideally that can be performed at home," said Tony Lemmo, CEO of the manufacturing company BioDot.The company's technology is being used by over 70 manufacturers worldwide making COVID-19 antigen, antibody, and PCR tests. Their automated platforms dispense nanoliter/picoliter amounts of reagent onto the tests accurately and fast.Lemmo says just one of their systems can support the production of roughly 100 million COVID-19 tests per year, helping to make high-volume production possible.“We knew we were going to be called on by customers to manufacture more equipment to provide them the ability to manufacture more tests," said Lemmo. To meet customer demand, BioDot increased staffing and built a new facility, compressing production time from months to weeks. The FDA recently authorized the first rapid at-home test that can deliver results in 30 minutes, eliminating the need for a lab to test the sample. But the molecular single-use test will only be available to patients with a doctor's prescription who are suspected of being infected with COVID-19.Companies developing tests hope the FDA will soon authorize another at-home testing tool: the rapid antigen test.These inexpensive tests provide results within minutes, and companies developing them say millions could be sold without a doctor's referral.“From what we’re hearing, it’s really just a matter of possibly months before there’s at least sufficient data to be able to support an at-home use of a test like an antigen test," said Lemmo.Lemmo says if authorized by the FDA, manufacturers could make millions of these tests in a matter of months. But antigen tests are less accurate, and the FDA wants to ensure they'll be simple enough for people to use at home. There are also concerns over how the data will be reported to health authorities. “I think any at-home testing or massive rollout of a test into the communities needs to be done very carefully and with a lot of education around it," said Clinical Lab Director Melissa Miller. Dr. Miller is a professor of pathology and laboratory medicine at the University of North Carolina Chapel Hill and Medical Director for the Clinical Microbiology Lab for the Medical Center.She worries the inaccuracies of these tests could eventually lead the public to lose trust in all testing. “Even at 98 percent specificity, which is very, very high. That means you’re going to have a false positive two out of every 100. If you started testing a hundred million people, this is millions of people who have a false-positive test," said Dr. Miller. She says this could lead to healthy people isolating and missing work or school unnecessarily, and false-negative results could give people a false sense of security. “These rapid antigen tests were pushed out to skilled nursing facilities; this is a very high-risk patient population. This is actually where you want a very accurate test," said Dr. Miller. She says it’s unclear how well antigen tests detect the virus in asymptomatic patients but agrees more data is needed to figure that out.“It might make more sense for K-12 schools, or even college settings, where there’s less risk for a poor outcome if you have a false positive or a false negative," said Dr. Miller. But with a growing demand for convenient at-home testing, manufacturers are hopeful that in the months ahead, the FDA will soon open the door to new solutions. 3889

来源：资阳报